The pathogenesis of classical Hodgkin's lymphoma: What can we learn from analyses of genomic alterations in Hodgkin and Reed-Sternberg cells?

Haematologica

Volumn 93, Issue 9, 2008, Pages 1292-1295

  Janz, Martin ^a   Mathas, Stephan ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G;

APOPTOSIS; DOWN REGULATION; HODGKIN DISEASE; HUMAN; IMMUNOHISTOCHEMISTRY; KARYOTYPE; MUTATION; PATHOGENESIS; REED STERNBERG CELL; REVIEW;

GENOME; HODGKIN DISEASE; HUMANS; REED-STERNBERG CELLS; SIGNAL TRANSDUCTION;

EID: 50849105768     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.13614     Document Type: Review

References (24)

1. Re D, Küppers R, Diehl V. Molecular pathogenesis of Hodgkin's lymphoma. J Clin Oncol 2005;23:6379-86.
2. Küppers R, Rajewsky K. The origin of Hodgkin and Reed/Sternberg cells in Hodgkin's disease. Annu Rev Immunol 1998;16:471-93.
3. Diehl V, Engert A, Re D. New strategies for the treatment of advanced-stage Hodgkin's lymphoma. Hematol Oncol Clin North Am 2007;21:897-914.
4. Irsch J, Nitsch S, Hansmann ML, Rajewsky K, Tesch H, Diehl V, et al. Isolation of viable Hodgkin and Reed-Sternberg cells from Hodgkin disease tissues. Proc Natl Acad Sci USA 1998;95:10117-22.
5. Hartmann S, Martin-Subero JI, Gesk S, Hüsken J, Giefing M, Nagel I, et al. Detection of genomic imbalances in microdissected Hodgkin- and Reed-Sternberg cells of classical Hodgkin's lymphoma by array-based comparative genomic hybridization. Haematologica 2008;93:1318-26.
6. Mathas S, Janz M, Hummel F, Hummel M, Wollert-Wulf B, Lusatis S, et al. Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma. Nat Immunol 2006;7:207-15.
7. Jundt F, Acikgöz O, Kwon SH, Schwarzer R, Anagnostopoulos I, Wiesner B, et al. Aberrant expression of Notch1 interferes with the B-lymphoid phenotype of neoplastic B cells in classical Hodgkin lymphoma. Leukemia 2008;doi:10.1038/leu.2008.101.
8. Joos S, Granzow M, Holtgreve-Grez H, Siebert R, Harder L, Martin-Subero JI, et al. Hodgkin's lymphoma cell lines are characterized by frequent aberrations on chromosomes 2p and 9p including REL and JAK2. Int J Cancer 2003;103:489-95.
9. + Hodgkin cells. Cancer Res 2000;60:549-52.
10. Falzetti D, Crescenzi B, Matteuci C, Falini B, Martelli MF, Van Den Berghe H, et al. Genomic instability and recurrent breakpoints are main cytogenetic findings in Hodgkin's disease. Haematologica 1999;84:298-305.
11. Drexler HG. Recent results on the biology of Hodgkin and Reed-Sternberg cells. I. Biopsy material. Leuk Lymphoma 1992;8:283-313.
12. Martin-Subero JI, Klapper W, Sotnikova A, Callet-Bauchu E, Harder L, Bastard C, et al. Chromosomal breakpoints affecting immunoglobulin loci are recurrent in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma. Cancer Res 2006;66:10332-8.
13. Renne C, Martin-Subero JI, Eickernjäger M, Hansmann ML, Küppers R, Siebert R, et al. Aberrant expression of ID2, a suppressor of B-cell-specific gene expression, in Hodgkin's lymphoma. Am J Pathol 2006;169:655-64.
14. Schmitz R, Renne C, Rosenquist R, Tinguely M, Distler V, Menestrina F, et al. Insights into the multistep transformation process of lymphomas: IgH-associated translocations and tumor suppressor gene mutations in clonally related composite Hodgkin's and non-Hodgkin's lymphomas. Leukemia 2005;19:1452-8.
15. Jansen MP, Hopman AH, Bot FJ, Haesevoets A, Stevens-Kroef MJ, Arends JW, et al. Morphologically normal, CD30-negative B-lymphocytes with chromosome aberrations in classical Hodgkin's disease: the progenitor cell of the malignant clone? J Pathol 1999;189:527-32.
16. Emmerich F, Meiser M, Hummel M, Demel G, Foss HD, Jundt F, et al. Overexpression of I kappa B alpha without inhibition of NF-kappaB activity and mutations in the I kappa B alpha gene in Reed-Sternberg cells. Blood 1999;94:3129-34.
17. Martin-Subero JI, Wlodarska I, Bastard C, Picquenot JM, Hoppner J, Giefing M, et al. Chromosomal rearrangements involving the BCL3 locus are recurrent in classical Hodgkin and peripheral T-cell lymphoma. Blood 2006;108:401-2.
18. Weniger MA, Melzner I, Menz CK, Wegener S, Bucur AJ, Dorsch K, et al. Mutations of the tumor suppressor gene SOCS-1 in classical Hodgkin lymphoma are frequent and associated with nuclear phospho-STAT5 accumulation. Oncogene 2006;25:2679-84.
19. Lemoine FJ, Marriott SJ. Genomic instability driven by the human T-cell leukemia virus type I (HTLV-I) oncoprotein, Tax. Oncogene 2002;21:7230-4.
20. Bose S, Starczynski J, Chukwuma M, Baumforth K, Wei W, Morgan S, et al. Down-regulation of ATM protein in HRS cells of nodular sclerosis Hodgkin's lymphoma in children occurs in the absence of ATM gene inactivation. J Pathol 2007;213:329-36.
21. Dutton A, Woodman CB, Chukwuma MB, Last JI, Wei W, Vockerodt M, et al. Bmi-1 is induced by the Epstein-Barr virus oncogene LMP1 and regulates the expression of viral target genes in Hodgkin lymphoma cells. Blood 2007;109:2597-603.
22. Lavin MF, Birrell G, Chen P, Kozlov S, Scott S, Gueven N. ATM signaling and genomic stability in response to DNA damage. Mutat Res 2005;569:123-32.
23. Janz M, Stühmer T, Vassilev LT, Bargou RC. Pharmacologic activation of p53-dependent and p53-independent apoptotic pathways in Hodgkin/Reed- Sternberg cells. Leukemia 2007;21:772-9.
24. Montesinos-Rongen M, Roers A, Küppers R, Rajewsky K, Hansmann ML. Mutation of the p53 gene is not a typical feature of Hodgkin and Reed-Sternberg cells in Hodgkin's disease. Blood 1999;94:1755-60.